Sign In
Buy NMTC
$1.69
-0.0100 (-0.588%)
At Close: Jul 31, 2026
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
07:30am, Thursday, 14'th Aug 2025
Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq:
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
12:12pm, Thursday, 31'st Jul 2025
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
08:30am, Thursday, 31'st Jul 2025
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office
08:30am, Wednesday, 23'rd Jul 2025
Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)
NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System
08:30am, Monday, 23'rd Jun 2025
Patient Treated with OneRF ® Ablation System Previously Experienced up to 10 Seizures a Day EDEN PRAIRIE, Minn., June 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: N
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
08:30am, Tuesday, 03'rd Jun 2025
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025
01:05pm, Thursday, 29'th May 2025
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript
09:46am, Tuesday, 13'th May 2025
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Dave Rosa – CEO Ron McClurg – CFO Chris Volker - COO Conferen
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
07:30am, Tuesday, 13'th May 2025
Filed 510(k)Submission with FDA for OneRF ® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor
08:30am, Monday, 12'th May 2025
Significant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference
04:01pm, Monday, 05'th May 2025
Eden Prairie, Minnesota--(Newsfile Corp. - May 5, 2025) - NeuroOne Medical (NASDAQ: NMTC), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2
NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time
09:55am, Thursday, 01'st May 2025
EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
09:00am, Wednesday, 23'rd Apr 2025
Multi-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical Treatments Submission Completed Earlier Than Anticipated EDEN PRAIRIE, Minn., April 23, 2025 (GLOBE NEWSWIRE) -- NeuroO
NeuroOne® Issues Letter to Shareholders
09:00am, Wednesday, 16'th Apr 2025
Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Cor
NeuroOne® OneRF® Technology Success Story Featured on Fox News
09:00am, Monday, 14'th Apr 2025
Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Na
